PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Rosemere Cancer Centre, Preston, Lancashire Teaching Hospitals, NHS Foundation, UK; The Christie NHS Foundation Trust, Manchester, UK.\', \'Division of Cancer Sciences, University of Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK.\', \'Mount Vernon Cancer Centre, Northwood, UK; Division of Cancer Sciences, University of Manchester, UK.\', \'The Beacon Centre, Musgrove Park Hospital, Taunton and Somerset NHS Foundation Trust, Taunton, UK.\', \'Institute of Cancer Research, London, UK; Royal Marsden Hospital, London, UK.\', \'The Rosemere Cancer Centre, Preston, Lancashire Teaching Hospitals, NHS Foundation, UK; Division of Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK. Electronic address: alison.birtle@lthtr.nhs.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0936-6555(20)30161-810.1016/j.clon.2020.04.005
?:hasPublicationType
?:journal
  • Clinical oncology (Royal College of Radiologists (Great Britain))
is ?:pmid of
?:pmid
?:pmid
  • 32389318
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic - Rapid Review.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all